India has moved from a tuberculosis (TB) control program to eliminating TB through its National Strategic Plan for TB Elimination (2017-2025). Key challenges include engaging private providers, addressing drug-resistant TB, and preventing new TB cases. The plan aims to reduce TB incidence and mortality by 80% and 90% respectively by 2025. Strategies include engaging private providers, active case finding, addressing social determinants, and a multisectoral approach. The government's digital Nikshay program tracks TB cases and outcomes nationwide to support elimination goals.
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
After the successful NSP 2017-2025,Goi is lauching NSP 2017-2025 for elimination of TB on 24th march( World TB day ) 2017. Module is on MOHFW site but i have try to keep it brief,hope its ll be useful specially for academic and administrative purposes.
This ppt contains all the information about Revised NationalTuberculosis Control programme (RNTCP) It is useful for students of the medical field learning Preventive and social medicine, Swasthavritta (Ayurved) and everyone who is interested in in knowing about it.
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxKritikaDhawan9
Acquired immunodeficiency syndrome (AIDS) is a chronic , potentially life, threating condition caused by the human immunodeficiency virus(HIV), a human retrovirus . By, damaging your immune system , HIV interferes with your body's ability to fight infection and disease.
HIV uses the machinery of the CD4 cells to multiply and spread throughout the body .
The international health regulations (IHR) is an agreement among 194 countries, including all WHO member countries ,to work together for healthy security of the world. Under the IHR, all countries need to report all events of international public health impact
NATIONAL AIDS CONTROL PROGRAMME(NACP) PPT BY KRITIKA.pptxKritikaDhawan9
Acquired immunodeficiency syndrome (AIDS) is a chronic , potentially life, threating condition caused by the human immunodeficiency virus(HIV), a human retrovirus . By, damaging your immune system , HIV interferes with your body's ability to fight infection and disease.
HIV uses the machinery of the CD4 cells to multiply and spread throughout the body .
The international health regulations (IHR) is an agreement among 194 countries, including all WHO member countries ,to work together for healthy security of the world. Under the IHR, all countries need to report all events of international public health impact
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
3. National TB Control Programme (NTCP)
launched by Government of India during 1962
two survey
reports
ICMR, done during 1955-58,
that TB was a major public
health problem, 1.5 percent of
the population above 5 years
was suffering from
radiologically active TB and
0.4 percent of them infectious
National TB Institute (NTC)
Bangalore during 1955 to 56 :
1. That nearly 50 percent of the cases
do not come to health care facility
for treatment
2. That domiciliary treatment is as
effective as institutional treatment
3. That the expenditure incurred for
treating 20-25 TB cases in the
sanitorium, can suffice to serve the
population of about 1500 through
establishment of TB clinics.
4. Objectives of NTCP
• Short-term objectives: –
- To detect and treat as many cases of TB as possible among outpatients
- To vaccinate the newborns with BCG
• Long-term objectives: –
-To reduce the problem of TB in the community to such a low level that it ceases to be a
public health problem, i.e. one infectious case should infect less than one new person
annually and the prevalence of infection among children below 14 years should be brought
down to les than 1 percent from 30 percent level then.
5. The organizations established for NTCP has 3 tiers: central, district and peripheral.
Five treatment regimen (R1-R5). long course chemotherapy for at least 1.5 years.
Short course chemotherapy was introduced during 1972.
It was centered around Rifampicin and INH.(regimen A & B).
Success rate was unacceptably low and death and default rates was high.
Inspite of a nation wide network of facilities, NTCP failed to yield satisfactory results.
Situation of TB remained same. It remained as a major public health problem .
On the other hand, there was increased incidence of MDR-TB cases and also the emergence of
HIV infection made the situation still worst.
6. In 1992, Government Of India (GOI) along with WHO and SIDA reviewed the TB situation
in the country. and came up with following conclusions : -
1. NTP had managerial weaknesses
2. Inadequate funding
3. Over-reliance on X-ray for diagnosis
4. Frequent interrupted supplies of drugs
5. Low rates of treatment completion
7. In 1993, because of emergence of HIV pandemic and increased incidence of MDR-TB
cases, WHO declared tuberculosis as ‘Global Emergency’.
In 1993, GOI intensified and revised the NTCP and renamed and launched as ‘revised
national tuberculosis control program’(RNTCP) . It was launched in 1993 as a pilot
project and expanded in 1997, with a plan to cover the entire country by 2004, in a
phased manner.
‘Revised National Tuberculosis Control Program’
8. The objectives of the RNTCP are :
1. Achievement of at least 85 % cure rate of infectious cases of tuberculosis, through
DOTS involving peripheral health functionaries.
2. Augmentation of case finding activities through quality sputum microscopy to
detect at least 70 % of estimated cases.
9. Directly Observed Treatment Short-course (DOTS) strategy adopted by RNTCP initially had
the following five main components:
1. Political will and administrative commitment.
2. Diagnosis by quality assured sputum smear microscopy.
3. Adequate supply of quality assured short course chemotherapy drugs.
4. Directly observed treatment.
5. Systematic monitoring and accountability.
10. SN NTP RNTCP
1 NAME National TB Control Program Revised National TB Control Program
2 Objective The objective was case detection
and treatment
70% case detection and 85% cure rate
3 Functional unit District TB center Tuberculosis unit
4 Case finding Active by health care worker ‘passive’ by quality microscopy.
5 sputum smear
examination
one two
6 Treatment regimen Many standardized
7 Supervision of
chemotherapy
No Yes by DOTS agent.
8 Drug supply Not regular “patient wise boxes”
9 Follow up Not regular regular
10 Case detection rate and
success rate
<50% >85%
11. In 2006, STOP TB strategy was announced by WHO and adopted by RNTCP.
The components are as follows :
1. Pursuing quality DOTS - expansion and enhancement.
2. Addressing TB/HIV and MOR-TB.
3. Contributing to health system strengthening.
4. Engaging all care providers.
5. Empowering patients and communities.
6. Enabling and promoting research (diagnosis, treatment, vaccine).
12. DOTS-Plus
• This was launched by WHO during the year 2000 and by RNTCP in India during 2007.
• DOTS-plus program should strengthen the basic DOTS strategy. Since the treatment of
MDR-TB cases is very complex, treatment is given as per the internationally recommended
DOTS-Plus guidelines, in the designated RNTCP DOTS-Plus sites, one for each state that
will have ready access to sputum culture and susceptibility testing laboratory, i.e. IRL.
13.
14.
15.
16. In 2014, the World
Health Assembly
unanimously approved
to end global TB
epidemic by "End TB
Strategy" , a 20 year
programme with
vision of a world with
zero death, disease
and suffering due to
TB.
17. NATIONAL STRATEGIC PLAN FOR TB ELIMINATION (2017-2025)
VISION
The VISION is - TB free India with zero deaths, disease and poverty due to
TB
OBJECTIVE
1. Find all drug sensitive TB and drug resistant TB cases with an emphasis on
reaching TB patients seeking care from private providers, and undiagnosed TB
in high-risk populations.
2. Initiate and sustain all patients on appropriate anti-TB treatment wherever
they seek care, with patient friendly systems and social support.
3. Prevent the emergence of TB in susceptible populations.
4. Build and strengthen enabling policies, empowered institutions, additional
human resources with enhanced capacities, and provide adequate financial
resources.
18. KEY STRATEGIES
1. Private sector engagement
2. Active case finding
3. Drug resistant TB case management
4. Addresssing social determinants including nutrition.
5. Robust surveillance system.
6. Community engagement and multisector approach.
EXPECTED
OUTCOME
The aim of the National Strategic Plan is to achieve elimination of TB
by 2025. During plan period, targets for TB are:
1. 80% reduction in TB incidence (i.e . reduction from 211 per lakh to
43 per lakh)
2. 90% reduction in TB mortality (i.e. reduction from 32 per lakh to 3
per lakh
3. 0% patient having catastrophic expenditure due to TB
20. S
N
IMPACT INDICATORS 2015 2020 2023 2025
1 Estimated TB incidence rate ( per lakh) 217 142 77 44
2 Estimated TB mortality (per lakh) 32 15 6 3
3 Estimated TB prevalence (per lakh) 320 170 90 65
4 Families suffering catastrophic cost due to TB 35% 0% 0% 0%
5 Total TB patient notifications (in millions) 1.74 3.6 2.7 2
6 Total TB patients private provider notifications (in
millions)
0.19 2 1.5 1.2
21. National AIDS Control Program
National Tobacco
Control Program
Rashtriya Bal
Swasthya
Karyakram
National Programme for
Prevention and Control
of Cancer, Diabetes,
Cardiovascular Diseases
and Stroke
Poshan Abhiyaan
Ayushman Bharat –
Health and Wellness
Centres
Collaborations to address risk factors of TB
22. ENDTB SUMMIT
13TH MARCH 2018
• Landmark event towards compete
elimination of TB from the country
• Hon’ble Prime Minister announced
targets for Ending TB by 2025, much
ahead of the global SDG targets of
2030.
• Emphasized importance of working
together for the cause as the
disease is inked to the betterment
of the lives of the poor .
23. Strengthening Case Finding in the Private Sector
Schedule H1 Implementation: The number of
chemists registered in Nikshay increased from
15221 in 2017 to over 43000 chemists notifying
20,609 TB cases in 2019.
Mandatory Notification of TB: Gazette
notification issued in March 2018; Provisions
of Sections 269 and 270 of the Indian Penal
Code (IPC) in 2019
Patient Provider Support Agency through JEET
and Domestic Resources: From 48 PPSAs in 2017
to 220 PPSAs in 2019 and 266 PPSAs in 2020.
67.8%
Increase in
private sector
notification
from 3.8
lakhs in 2017
to 5.6 lakhs in
2020.
24. NIKSHAY
NIKSHAY : TB surveillance using case based web based IT system (19) Central TB Division
in collaboration with National Informatics Centre has undertaken the initiative to develop a
case based web based application named Nikshay. The word is combination of two Hindi
words NI and KSHAY, meaning eradication of TB.
25. This software was launched in May 2012 and has following functional components.
- Master management
- User details
- TB Patient registration and details of diagnosis. DOT provider, HIV status, follow-up, contact tracing,
outcomes.
- Details of solid and liquid culture and DST, LPA, CBNAAT details.
- DR-TB patient registration with details.
- Referral and transfer of patients.
- Private health facility registration and TB notification.
- Mobile application for TB notification.
- SMS alerts to patients on registration.
- SMS alerts to programme officers.
- Automated periodic reports:
a. Case finding
b. Sputum conversion
c. Treatment outcome.
26. Registered enteries till dec 2020-
1. Public health sector – 39136
2. Private health sector- 244508
3. Staff -267714
Number of TB PATIENTS NOTIFIED IN NIKSHAY FROM 2017 TO 2020-
80,42,008
Number of beneficiaries paid atleast 1 benefit since inception of npy in april 2018 to
dec 2020- 39,37,719
27. NIKSHAY DASHBOARD
Dashboard portal was launched in 2020.
Dashboard provide a visual representation of the various NTEP indicators to
users across all levels .
Allows monitoring and review of all levels against selected indicator.
28.
29. DIRECT BENEFIT TRANSFER (DBT)
DBT schemes under NTEP are as follows :
1. Nikshay Poshan Yojana (NPY)
2. Incentive to treatment supporters/ DOTS providers
3. Notification incentive to private providers.
4. Transport incentive to tribal TB patients
30. NIKSHAY PFMS
Bank
Patient
TB patients
provided
benefit
39
lakh
Public sector –
90%,
•Private – 23%
Covera
ge
• Rs. 500/- per month given to
every TB patient through DBT for
duration of treatment
• Scheme rolled out from April
2018
• Rs. 990.4 Cr amount disbursed to
beneficiaries from Apr’18 till date
30
Period - April 2018 till date
DBT: Direct Beneficiary Transfer; PFMS- Public Financial Management System
NIKSHAY Poshan Yojana
31. Incentive for Treatment
supporter
Incentive for
Informant
Travel support in Tribal
blocks
• Drug sensitive TB :
Rs. 1000/- at completion of
treatment
• Drug Resistant Case:
Rs.5000/- during treatment
• An Informant is
eligible for
incentive of
Rs. 500/- for a
confirmed TB case
• Rs. 750/- as travel
support for all TB
patients of tribal
blocks
Incentives
32. INCENTIVE TO PRIVATE SECTOR PROVIDERS FOR NOTIFICATION OF TB
PATIENTS
BENEFICIARY:-
Private Providers ( Private Practioner, Hospital, Laboratory And Chemist ) who notify
TB patients to National TB Elimination Programme .
INCENTIVE :-
INR 500 as a one time payment on notification.
INR 500 to Private Practitioner or Hospital for updating the patients’s treatment
outcome.
33. 33
Call Centre- NIKSHAY SAMPARK
TOLL FREE 1800-11-6666
Outbound & Inbound
Time – 7 to 11
Languages – 14
100 call centre agents
Pan-India coverage
Citizen – Patient – Providers
Counselli
ng Treatme
nt
Adheren
ce
Grievance
Redressal
Follow
Up
TB
Notificati
on
Informat
ion
Nikshay
Poshan
Yojana
Total Calls at TB Call Centre
May-18 to June-20
TB inbound Calls answered 719103
TB outbound calls dialled 1576963
COVID-19 inbound Call
answered 529413
34. INDICATOR STATUS
TOTAL NOTIFICATION (2020) 18,05,670
PRIVATE NOTIFICATION(2020) 4,79,905
PUBLIC NOTIFIVCSTION(2020) 13,25,765
ON TREATMENT (2020) 17,10,923
DIED (2019) 89,823
TREATMENT SUCCESS (2019) 19,05,920
LOST TO FOLLOW UP(2019) 81,306
TREATMENT FAILURE (2019) 13,781
35. 1. Under reporting and uncertain care of TB patients in private sector.
2. Reaching the unreached – Slums, Tribal, vulnerable.
3. Drug Resistant TB.
4. Co-morbidities – HIV, Diabetes.
5. Under nutrition, overcrowding.
6. Lack of awareness and poor health seeking behaviour lead to delay in diagnosis.
Key Challenges
, likewise fall in total notification from 2018 to 2019 42974- 2019,
Cases notified 20,980 TB patients in 2018 and 20,609 in 2019. - chemists
2017- 15221 chemists
Undernutrition is an established risk factor for progression of latent TB infection to active TB and contributes to 7 lakh TB patients annually
To address this critical determinant, Nikshay Poshan Yojana has been rolled out from April’2018, one of the largest social support schemes for TB patients globally.
Under this scheme, each TB patient is eligible for Rs. 500 per month for the duration of TB treatment and benefits are transferred directly in their bank account.
Since the inception of the scheme, 39 lakh TB patients have been benefited from the scheme from April 2018 till date.
Challenges in NPY includes the following:
Non availability of bank accounts of patients
Patient’s non-acceptance of benefits in the private sector where the coverage is a mere 23%.
In addition to Nikshay Poshan Yojana, TB programme has made the provision of incentives for informants, treatment supporters and TB patients in tribal area as well.
Treatment supporter who observes the patient adherence during the course of treatment is eligible for Rs. 1000 per patient for completion of treatment of drug sensitive TB and Rs. 5000 for supporting drug resistant TB patient. An informant is eligible to get incentive of Rs. 500/- on diagnosis of TB patients from a patient referred for testing.
TB patients in tribal area have been paid Rs. 750/- for travel support.